Evolution of neutralizing antibodies through vaccination and breakthrough infections in the era of COVID-19 endemicity
Description
Despite a high vaccination rate, the COVID-19 pandemic continues with immune-evading Omicron variants. The success of additional antigenic stimulation through breakthrough infection (BI) and updated vaccination in overcoming antigenic imprinting
